Biolife Sciences (Biolife Sciences) Ending Cash Position : $0.04 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Ending Cash Position?

Biolife Sciences's Ending Cash Position for the quarter that ended in May. 2008 was $0.04 Mil.

Biolife Sciences's quarterly Ending Cash Position declined from Nov. 2007 ($0.40 Mil) to Feb. 2008 ($0.02 Mil) but then increased from Feb. 2008 ($0.02 Mil) to May. 2008 ($0.04 Mil).

Biolife Sciences's annual Ending Cash Position declined from Nov. 2005 ($1.19 Mil) to Nov. 2006 ($0.07 Mil) but then increased from Nov. 2006 ($0.07 Mil) to Nov. 2007 ($0.40 Mil).

Biolife Sciences Ending Cash Position Historical Data

The historical data trend for Biolife Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Ending Cash Position Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Ending Cash Position

1.19

0.07

0.40

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Ending Cash Position	Get a 7-Day Free Trial										0.10	0.09	0.40	0.02	0.04

Biolife Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biolife Sciences's Ending Cash Position for the fiscal year that ended in Nov. 2007 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.072	+	0.332
	=	0.40

Biolife Sciences's Ending Cash Position for the quarter that ended in May. 2008 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.019	+	0.02
	=	0.04

Biolife Sciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020